CONSUN PHARMACEUTICAL GRP LIMITED revenue breakdown overview

CONSUN PHARMACEUTICAL GRP LIMITED revenue for the last year amounted to 2.85 B HKD, the most of which — 1.92 B HKD — came from its highest performing source at the moment, Kidney Medicines, the year earlier bringing 1.83 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought CONSUN PHARMACEUTICAL GRP LIMITED 2.86 B HKD, and the year before that — 2.72 B HKD.